APA (7th ed.) Citation

Temirbulatov, I. I., Kryukov, A. V., Mirzaev, K. B., Denisenko, N. P., Abdullaev, S. P., Petrova, A. V., . . . Sychev, D. A. (2023). Pharmacogenetic Markers of Favipiravir Safety in COVID-19 Treatment. LLC "Publishing House OKI".

Chicago Style (17th ed.) Citation

Temirbulatov, I. I., A. V. Kryukov, K. B. Mirzaev, N. P. Denisenko, S. P. Abdullaev, A. V. Petrova, E. P. Tkach, A. V. Shipacheva, and D. A. Sychev. Pharmacogenetic Markers of Favipiravir Safety in COVID-19 Treatment. LLC "Publishing House OKI", 2023.

MLA (9th ed.) Citation

Temirbulatov, I. I., et al. Pharmacogenetic Markers of Favipiravir Safety in COVID-19 Treatment. LLC "Publishing House OKI", 2023.